火星财经消息，翰宇药业(300199.SZ)午后拉升涨停，报价 24.32 元，股价创 2022 年 12 月以来新高。消息面上，翰宇药业与数字资产平台 Ku­C­o­in 正式签署战略合作意向书，双方拟共同探索在香港共同推进中国内地首个以“创新药研发未来收益权”为底层资产的 RWA(Re­al Wo­r­ld As­s­et)代币化试点项目。根据协议，翰宇药业将以其在 GLP-1 类多肽重磅药物领域的技术积累与研发管线为基础资产，Ku­C­o­in 则将发挥其在区块链技术、RWA 全流程解决方案和全球合规资源方面的优势，为该项目提供链上映射、资产通证化、交易撮合、收益分配等一体化支持。（格隆汇）

<div>火星财经消息，翰宇药业(300199.SZ)午后拉升涨停，报价 24.32 元，股价创 2022 年 12 月以来新高。消息面上，翰宇药业与数字资产平台 Ku­C­o­in 正式签署战略合作意向书，双方拟共同探索在香港共同推进中国内地首个以“创新药研发未来收益权”为底层资产的 RWA(Re­al Wo­r­ld As­s­et)代币化试点项目。根据协议，翰宇药业将以其在 GLP-1 类多肽重磅药物领域的技术积累与研发管线为基础资产，Ku­C­o­in 则将发挥其在区块链技术、RWA 全流程解决方案和全球合规资源方面的优势，为该项目提供链上映射、资产通证化、交易撮合、收益分配等一体化支持。（格隆汇）</div>

翰宇药业与数字资产平台 Ku­C­o­in 签署战略合作意向书，股价拉升涨停

<火星财经> Mars Finance News: Hanyou Pharmaceutical (300199.SZ) surged to the daily limit in the afternoon, trading at 24.32 yuan, reaching a new high since December 2022. According to the news, Hanyou Pharmaceutical has officially signed a strategic cooperation agreement with the digital asset platform Kucoin, with both parties intending to jointly explore the first RWA (Real World Asset) tokenization pilot project in mainland China based on "innovative drug research and development future revenue rights" in Hong Kong. According to the agreement, Hanyou Pharmaceutical will use its technical accumulation and R&D pipeline in the GLP-1 polypeptide heavyweight drug field as the underlying assets, while Kucoin will leverage its advantages in blockchain technology, RWA full-process solutions, and global compliance resources to provide integrated support for the project, including on-chain mapping, asset tokenization, transaction matching, and revenue distribution. (Gelonghui)

<div>Mars Finance News: Hanyu Pharmaceutical (300199.SZ) surged to the daily limit in the afternoon, trading at 24.32 yuan, reaching a new high since December 2022. According to the news, Hanyu Pharmaceutical has officially signed a strategic cooperation memorandum with the digital asset platform KuCoin, with both parties intending to jointly explore the first RWA (Real World Asset) tokenization pilot project in mainland China based on "innovative drug research and development future revenue rights" in Hong Kong. According to the agreement, Hanyu Pharmaceutical will use its technological accumulation and R&D pipeline in the GLP-1 polypeptide heavyweight drug field as the underlying assets, while KuCoin will leverage its advantages in blockchain technology, RWA full-process solutions, and global compliance resources to provide integrated support for the project, including on-chain mapping, asset tokenization, transaction matching, and revenue distribution. (Gelonghui)</div>

Hanyu Pharmaceuticals signed a letter of intent for strategic cooperation with digital asset platform KuCoin, sending its stock price soaring to its daily limit.

As Bitcoin continues to languish below the $90,000 mark, CryptoQuant analysts are ready to call it: BTC has entered a bear market.

Bitcoin Has Entered a Bear Market, Say Analysts—Here's Why

If you persevere and find your strengths, you will be rewarded.
Article author: 0xJeff
Article source: TechFlow TechFlow
2025 was filled with unprecedented turmoil and change. We welcomed a US president who was reportedly a supporter of cryptocurrencies and artificial intelligence. However, instead of the expected bull market, 2025 became a year of "massacre" for the entire industry.
Most Altcoin experienced a crash of 80%-99% in 2025.
Bitcoin's market capitalization share has returned to 2019-2020 levels (over 6...).

7 Crypto Trends and Lessons You Must Know in 2026

Source: Arthur Hayes, founder of BitMEX; Translated by: Jinse Finance
If I had an online dating profile, it would probably look something like this:
Irish politicians and central bank officials have created euphemisms and abbreviations to describe the act of printing money.
This article will focus on two apt examples:
Quantitative easing (QE)
Reserve Management Purchases (RMP)
The new abbreviation RMP comes from the Federal Reserve's most recent interest rate meeting on December 10th...